Associates of Cape Cod, Inc.

Associates of Cape Cod, Inc. (ACC) is a specialist manufacturer of endotoxin and glucan testing reagents, instrumentation, and software for pharmaceutical, biological product, and medical device manufacturers. The company's primary product portfolio centers on Limulus Amebocyte Lysate (LAL) reagents—derived from horseshoe crab blood—used to detect bacterial endotoxins in injectable pharmaceuticals, biologics, and medical devices. ACC also manufactures recombinant endotoxin testing (rBET) alternatives, including recombinant cascade reagents, positioning itself as a supplier of both traditional and next-generation pyrogen detection solutions. The Pyros® eXpress software platform provides integrated quantitative analysis and data management for endotoxin and glucan detection testing across glass tube and plate reader formats, with documented compatibility with Agilent BioTek Epoch 2 microplate readers. ACC operates a Contract Test Services (CTS) laboratory offering third-party endotoxin and glucan contamination testing. The company supports customers through free consultation, methodology guidance, and technical training. ACC maintains a demonstrated commitment to sustainability, including the Horseshoe Crab Sustainability Project (having reared and released over 1 million juvenile horseshoe crabs) and environmental responsibility in manufacturing. The company supplies the regulated biomedical testing market, serving manufacturers of injectable drugs, biologics, and medical devices requiring endotoxin testing for regulatory compliance (FDA, pharmacopeial).